Serum 25-hydroxyvitamin D and the incidence of peripheral artery disease in the elderly: The Pro.V.A study

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 7, 2015, Pages 726-734

  Veronese, Nicola ^a   De Rui, Marina ^a   Bolzetta, Francesco ^a   Toffanello, Elena Debora ^a   Coin, Alessandra ^a   Zambon, Sabina ^a,b   Corti, Maria Chiara ^c   Baggio, Giovannella ^d   Perissinotto, Egle ^a   Maggi, Stefania ^b   Crepaldi, Gaetano ^b   Manzato, Enzo ^a,b   Sergi, Giuseppe ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c Division of Health Care Planning and Evaluation of the Regione Veneto   (Italy)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Cardiovascular disease; Elderly; Peripheral artery disease; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNORADIOMETRIC ASSAY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; ANALOGS AND DERIVATIVES; BLOOD; REGRESSION ANALYSIS;

AGED; ANKLE BRACHIAL INDEX; FEMALE; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; REGRESSION ANALYSIS; VITAMIN D;

EID: 84937919113     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.28134     Document Type: Article

References (33)

1. 1 Aronow WS: Peripheral arterial disease in the elderly. Clin Interv Aging, 2007; 2: 645-654
2. 2 Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N: 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation, 2005; 111: 1666-1671
3. 3 Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1, 25-dihydroxyvitamin D (3) is a negative endocrine regulator of the renin angiotensin system. J Clin Invest, 2002; 110: 229-238
4. 4 O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU: 1,25- dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol, 1997; 272: H1751-H1758
5. 5 Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R: 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation, 2000; 102: 2867-2872
6. 6 Şeker T, Gür M, Kuloglu O, Kalkan GY, Şahin DY, Türkoglu C, Elbasan Z, Baykan AO, Gözübüyük G, Çayli M: Serum 25-hydroxyvitamin D is associated with both arterial and ventricular stiffness in healthy subjects. J Cardiol, 2013; 62: 361-365
7. 7 van de Luijtgaarden KM, Voûte MT, Hoeks SE, Bakker EJ, Chonchol M, Stolker RJ, Rouwet EV, Verhagen HJ: Vitamin D deficiency may be an independent risk factor for arterial disease. Eur J Vasc Endovasc Surg, 2012; 44: 301-306
8. 8 Fahrleitner-Pammer A, Obernosterer A, Pilger E, Dobnig H, Dimai HP, Leb G, Kudlacek S, Obermayer-Pietsch BM: Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos Int, 2005; 16: 319-324
9. 9 Fahrleitner A, Dobnig H, Obernosterer A, Pilger E, Leb G, Weber K, Kudlacek S, Obermayer-Pietsch BM: Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med, 2002; 17: 663-669
10. 10 Melamed ML, Muntner P, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P: Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol, 2008; 28: 1179-1185
11. 11 Reis JP, Michos ED, von Mühlen D, Miller ER 3rd: Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr, 2008; 88: 1469-1477
12. 12 McDermott MM, Liu K, Ferrucci L, Tian L, Guralnik J, Kopp P, Tao H, Van Horn L, Liao Y, Green D, Kibbe M, Criqui MH: Vitamin D status and functional performance in peripheral artery disease. Vasc Med, 2012; 17: 294-302
13. 13 Veronese N, Sergi G, De Rui M, Bolzetta F, Toffanello ED, Zambon S, Corti MC, Sartori L, Musacchio E, Baggio G, Crepaldi G, Perissinotto E, Manzato E: Serum 25-hydroxyvitamin D and incidence of diabetes in elderly people: The PRO.V.A. Study. J Clin Endocrinol Metab, 2014; 99: 2351-2358
14. 14 Veronese N, Bolzetta F, De Rui M, Zambon S, Corti MC, Musacchio E, Baggio G, Crepaldi G, Perissinotto E, Manzato E, Sergi G: Serum 25-hydroxyvitamin D and ortho-static hypotension in old people: The Pro. V.A. Study. Hypertension, 2014; 64: 481-486
15. 15 Pilz S, van den Hurk K, Nijpels G, Stehouwer CD, Van't Riet E, Kienreich K, Tomaschitz A, Dekker JM: Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: the Hoorn study. Nutr Metab Cardiovasc Dis, 2012; 22: 883-889
16. 16 Alvarez JA, Ashraf: A role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol, 2010; 2010: 351-385
17. 17 Corti MC, Guralnik JM, Sartori L, Baggio G, Manzato E, Pezzotti P, Barbato G, Zambon S, Ferrucci L, Minervini S, Musacchio E, Crepaldi G: The effect of cardiovascular and osteoarticular diseases on disability in older Italian men and women: rationale, design, and sample characteristics of the Progetto Veneto Anziani PRO.V.A. study. J Am Geriatr Soc, 2002; 50: 1535-1540
18. 18 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC E Working Group: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC E). J Vasc Surg, 2007 Jan; 45 Suppl S: S5-S67
19. 19 European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769-1818
20. 20 Holick MF, Chen TC: Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr, 2008; 87: 1080S-1086S
21. 21 De Rui M, Toffanello ED, Veronese N, Zambon S, Bolzetta F, Sartori L, Musacchio E, Corti MC, Baggio G, Crepaldi G, Perissinotto E, Manzato E, Sergi G: Vitamin D deficiency and leisure time activities in the elderly: are all pastimes the same? PLoS One, 2014 Apr 10; 9: e94805
22. 22 Kim HJ, Giovannucci E, Rosner B, Willett WC, Cho E: Longitudinal and secular trends in dietary supplement use: Nurses' Health Study and Health Professionals Follow-Up Study, 1986-2006. J Acad Nutr Diet, 2014; 114: 436-443
23. 23 Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA: Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol, 2001; 153: 666-672
24. 24 Merino J, Planas A, Elosua R, de Moner A, Gasol A, Contreras C, Vidal-Barraquer F, Clara A: Incidence and risk factors of peripheral arterial occlusive disease in a prospective cohort of 700 adult elderly men followed for 5 years. World J Surg, 2010; 34: 1975-1979
25. 25 Löpez-Jimenez L, Camafort M, Tiberio G, Carmona JA, Guijarro C, Martinez-Penalver F, Monreal M; FRENA Investigators: Secondary prevention of arterial disease in very elderly people: results from a prospective registry (FRENA). Angiology, 2008; 59: 427-434
26. 26 Baker MR, Peacock M, Nordin BE: The decline in vitamin D status with age. Age Ageing, 1980; 9: 249-252
27. 27 Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot Ld, Streppel M, Gardiner J, Ordönez-Mena JM, Perna L, Wilsgaard T, Rathmann W, Feskens E, Kamp-man E, Siganos G, Njolstad I, Mathiesen EB, Kubinova R, Pajak A, Topor-Madry R, Tamosiunas A, Hughes M, Kee F, Bobak M, Trichopoulou A, Boffetta P, Brenner H; Consortium on Health and Ageing: Network of Cohorts in Europe and the United States: Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ, 2014; 348: g36-56
28. 28 van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA: Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies. Am Heart J, 2013; 165: 655-664
29. 29 Folsom AR, Alonso A, Misialek JR, Michos ED, Selvin E, Eckfeldt JH, Coresh J, Pankow JS, Lutsey PL: Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities ARIC study. Am Heart J, 2014; 168: 296-302
30. 30 Mosele M, Coin A, Manzato E, Sarti S, Berton L, Bol-zetta F, Imoscopi A, Rinaldi G, Perissinotto E, Sergi G: Association between serum 25-hydroxyvitamin D levels, bone geometry, and bone mineral density in healthy older adults. J Gerontol A Biol Sci Med Sci, 2013; 68: 992-998
31. 31 Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G: Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol, 2010; 171: 903-908
32. 32 Manghat P, Sodi R, Swaminathan R: Phosphate homeo-stasis and disorders. Ann Clin Biochem, 2014; 51: 631-656
33. 33 van Wijk DF, Boekholdt SM, Wareham NJ, Ahmadi-Abhari S, Kastelein JJ, Stroes ES, Khaw KT: C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study. Arterioscler Thromb Vasc Biol, 2013; 33: 2888-2894